Amplifon SpAAMFPF 78 EV-to-EBITDA is 8.57 as of Jul. 11, 2026, which is 47% below its 10-year median of 16.19. GuruFocus rates AMFPF with a GF Score™ of 78/100 and a GF Value™ of $28.60 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 97 Medical Distribution companies, Amplifon SpA ranks better than 50.52% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Amplifon SpA's enterprise value is $4,798 Mil.
Amplifon SpA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $560 Mil. Therefore, Amplifon SpA's EV-to-EBITDA for today is 8.57.
The historical rank and industry rank for Amplifon SpA's EV-to-EBITDA or its related term are showing as below:
AMFPF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.71 Med: 16.19 Max: 26.4
Current: 8.89
During the past 13 years, the highest EV-to-EBITDA of Amplifon SpA was 26.40. The lowest was 6.71. And the median was 16.19.
AMFPF's EV-to-EBITDA is ranked better than 50.52% of 97
companies
in the Medical Distribution industry
Industry Median: 8.83
vs AMFPF: 8.89
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Amplifon SpA's PE Ratio (TTM) for today is calculated as:
Amplifon SpA's share price for today is $11.21.
Amplifon SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.359.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Amplifon SpA's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Amplifon SpA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplifon SpA EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amplifon SpA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Amplifon SpA's EV-to-EBITDA falls into.
Amplifon SpA's current Enterprise Value is $4,798 Mil.
Amplifon SpA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $560 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amplifon SpA (AMFPF) has a EV-to-EBITDA of 8.57 as of Jul. 11, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Amplifon SpA. This is 47% below median its historical median of 16.19. Over the past decade, Amplifon SpA's EV-to-EBITDA has ranged from 6.71 to 26.40. According to the industry distribution chart, Amplifon SpA ranks #48 out of 97 companies in the Medical Distribution industry, placing it in the top 49.5%.
Is Amplifon SpA's EV-to-EBITDA too high?
Amplifon SpA's current EV-to-EBITDA of 8.57 is 47% below median its 10-year median of 16.19. Over the past 10 years, this metric has ranged from a low of 6.71 to a high of 26.40. The Medical Distribution industry median EV-to-EBITDA is 8.83. Amplifon SpA's value of 8.57 is 2.9% below this industry median. Based on the distribution chart, Amplifon SpA ranks #48 out of 97 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Amplifon SpA has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Amplifon SpA's EV-to-EBITDA compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Amplifon SpA ranks #48 out of 97 companies for EV-to-EBITDA. This puts Amplifon SpA in the upper half of its industry. The industry median EV-to-EBITDA is 8.83. Amplifon SpA's value of 8.57 is 2.9% below this benchmark. Historically, Amplifon SpA's own EV-to-EBITDA has ranged from 6.71 to 26.40 over the past decade. While the company's 10-year median is 16.19 vs. the industry median of 8.83, Amplifon SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.83, based on 97 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amplifon SpA's current EV-to-EBITDA of 8.57 is 2.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Amplifon SpA. For the Medical Distribution industry, the median EV-to-EBITDA is 8.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amplifon SpA's current EV-to-EBITDA is 8.57, which is 47% below median its own 10-year median of 16.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amplifon SpA stock overvalued right now?
Based on GuruFocus' analysis, Amplifon SpA (AMFPF) is currently considered Possible Value Trap. The stock's GF Value™ is $28.60, compared to a current price of $11.21 — trading 60.8% below its estimated fair value. The current EV-to-EBITDA is 8.57, which is 47% below median its 10-year median of 16.19 and 2.9% below the Medical Distribution industry median of 8.83. Amplifon SpA's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Amplifon SpA (AMFPF), the current EV-to-EBITDA is 8.57 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amplifon SpA (AMFPF) Overvalued in 2026?
Based on GuruFocus' analysis, Amplifon SpA stock appears to be undervalued.
The current stock price of $11.21 is trading 60.8% below its estimated GF Value™ of $28.60.
GuruFocus considers Amplifon SpA to be Possible Value Trap.
Key valuation signals for AMFPF:
EV-to-EBITDA: 8.57 (47% below median its 10-year median of 16.19)
GF Value™: $28.60 vs. price of $11.21 (60.8% below fair value)
Industry Position: 2.9% below the Medical Distribution median (#48 of 97)
No single metric tells the full story. See the AMFPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.
78GF Score
Get the complete analysis for AMFPF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMFPF has been successfully added to your 
